The U.S. Department of Health and Human Services (HHS) and SAMHSA announced that federal workplace drug testing rules for cannabis will remain unchanged as marijuana's status as a Schedule I drug persists. Despite a presidential directive to expedite rescheduling to Schedule III, the agencies have made no revisions to testing panels or nomenclature for federal workers.

Federal Workplace Drug Testing Rules Remain Unchanged While Rescheduling Is Pending

Mar 16, 2026

Source:

Kyle Jaeger

Marijuana Moment

The federal government is hitting the brakes on updating drug testing policies for workers, proving once again that bureaucracy moves slower than a low-and-slow cure. Despite high-profile talk from the administration about fast-tracking marijuana’s move to Schedule III, the Department of Health and Human Services (HHS) recently confirmed that everything is staying exactly the same for now. Since cannabis is technically still a Schedule I substance, the standard testing panels and rules for federal employees haven't changed one bit.

While we did see some small wins recently with more accurate terminology—like finally distinguishing between Delta-9 THC and hemp-derived Delta-8—safety-sensitive workers under the Department of Transportation are still stuck with the old-school rules.

For the average toker, this is a frustrating reminder that "legalization" on paper doesn't always mean freedom in the workplace. It highlights the massive gap between shifting cultural vibes and rigid federal employment laws. Until rescheduling is actually finalized, many workers are still looking at outdated hurdles just for enjoying a plant that’s legal in half the country.